| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 6 |
| 1 | PEMETREXED | 6 |
| 2 | PEMETREXED DISODIUM | 6 |
| 3 | CARBOPLATIN | 5 |
| 4 | TRASTUZUMAB | 4 |
| 5 | AFATINIB | 3 |
| 6 | DOCETAXEL | 2 |
| 7 | DOCETAXEL ANHYDROUS | 2 |
| 8 | ZONGERTINIB | 2 |
| 9 | CISPLATIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZONGERTINIB | 2 | 0.0120 |
| 1 | AFATINIB | 3 | 0.0005 |
| 2 | NERATINIB | 1 | 0.0004 |
| 3 | RAMUCIRUMAB | 1 | 0.0002 |
| 4 | PEMETREXED DISODIUM | 6 | 0.0002 |
| 5 | TRASTUZUMAB | 4 | 0.0001 |
| 6 | BEVACIZUMAB | 6 | 0.0000 |
| 7 | CARBOPLATIN | 5 | 0.0000 |
| 8 | DOCETAXEL | 2 | 0.0000 |
| 9 | DOCETAXEL ANHYDROUS | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 5 | 0.0000 |